The human B cell response to IL-13 is dependent on cellular phenotype as well as mode of activation

Journal of Immunology

Volumn 163, Issue 6, 1999, Pages 3185-3193

  Ford, Dwayne ^a   Sheehan, Catherine ^a   Girasole, Christopher ^a   Priester, Rory ^a   Kouttab, Nicola ^a   Tigges, John ^a   King, Thomas C ^b   Luciani, Andrea ^a   Morgan, John W ^a   Maizel, Abby L ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; INTERLEUKIN 13;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL TYPE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANTIGENS, CD40; B-LYMPHOCYTE SUBSETS; CD40 LIGAND; CELL DIVISION; CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; INTERPHASE; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-2; RECEPTORS, INTERLEUKIN-4; RNA, MESSENGER; TONSIL;

EID: 0033568010     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Zubler, C. E., J. P. Galizzi, A. Valle, N. Harada, M. Howard, and J. Banchereau. 1990. Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation. Eur. J. Immunol. 20:551.
2. Mosley, B. M., M. Beckmann, M. CJ, R. Idzerda, S. Gimpel, T. VandenBos, D. Friend, A. Alpert, D. Anderson, J. Jackson, et al. 1989. Interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 89:335.
3. Aman, M. J., N. Tayebi, N. I. Obiri, R. K. Puri, W. S. Modi, and W. J. Leonard. 1996. cDNA cloning and characterization of the human interleukin 13 receptor α chain. J. Biol. Chem. 271:29265.
4. Miloux, B., P. Laurent, O. Bonnin, J. Lupker, D. Caput, N. Vita, and P. Ferrara. 1997. Cloning of the human IL-13 R α1 chain and reconstitution with the IL-4R α of a functional IL-4/IL-13 receptor complex. FEBS Lett. 401:163.
5. Gauchat, J., E. Schlangenhaut, N. Fong, R. Moser, M. Yamage, P. Jeannin, S. Alouani, G. Elson, L. Notarangelo, T. Wells, et al. 1997. A novel 4-kb interleukin-13 receptor α mRNA expressed in human B, T, and endothelial cells encoding an alternate type II interleukin-4/interleukin-13 receptor. Eur. J. Immunol 27:971.
6. Hilton, D. J., J.-G. Zhang, D. Metcalf, W. S. Alexander, N. A. Nicola, and T. A. Wilson. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93:497.
7. Caput, D., P. Laurent, M. Kaghad, J. M. Lelias, S. Lefort, N. Vita, and M. A. Ferrara. 1996. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J. Biol. Chem. 271:16921.
8. Donaldson, D. D., M. J. Whitters, L. J. Fitz, T. Y. Neben, H. Finnerty, S. L. Henderson, R. M. O'Hara, Jr., D. R. Beier, K. J. Turner, C. R. Wood, and M. Collins. 1998. The murine IL-13 receptor α 2: molecular cloning, characterization, and comparison with murine IL-13 receptor α1. J. Immunol. 161:2317.
9. Zhang, J. G., D. J. Hilton, T. A. Willson, C. McFarlane, B. A. Roberts, R. L. Moritz, R. J. Simpson, W. S. Alexander, D. Metcalf, and N. A. Nicola. 1997. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein: evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor α chains. J. Biol. Chem. 272:9474.
10. Aversa, G., J. Punnonen, B. Cocks, R. Malefyt, F. Vega, S. Zuarwski, G. Zuarwski, and J. Vries. 1993. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 and IL-13 induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med. 178:2213.
11. Debinski, W., R. Miner, P. Leland, N. I. Obiri, and R. K. Puri. 1996. Receptor for interleukin (IL)-13 does not interact with IL-4 but receptor for IL-4 interacts with IL-13 on human blioma cells. J. Biol. Chem. 271:22428.
12. Doucet, C., D. Brouty-Boye, C. Pottin-Clemenceau, G. W. Canonica, C. Jasmin, and B. Azzarone. 1998. Interleukin (IL)-4 and IL-13 act on human lung fibroblasts: implication in asthma. J. Clin. Invest. 101:2129.
13. Feng, N., S. M. Lugli, B. Schnyder, J. F. Gauchat, P. Graber, E. Schlagenhauf, B. Schnarr, M. Wiederkehr-Adam, A. Duschl, M. H. Heim, et al. 1998. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor α2. Lab. Invest. 78:591.
14. Graber, P., D. Gretener, S. Herren, J. P. Aubry. G. Elson, J. Poudrier, S. Lecoanet-Henchoz, S. Alouani, C. Losberger, J. Y. Bonnefoy, et al. 1998. The distribution of IL-13 receptor α expression on B cells, T cells, and monocytes and its regulation by IL-13 and IL-4. Eur. J. Immunol. 28:4286.
15. Kotowicz, K., R. E. Callard, K. Friedrich, D. J. Matthews, and N. Kline. 1996. Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor. Int. Immunol. 8:1915.
16. Murata, T., J. Taguchi, and R. K. Puri. 1998. Interleukin-13 receptor α1 but not α chain: a functional component of interleukin-4 receptors. Blood 91:3884.
17. Obiri, N. I., W. Debinski, W. J. Leonard, and R. K. Puri. 1995. Receptor for interleukin 13. J. Biol. Chem. 270:8797.
18. Obiri, N. I., P. Leland, T. Murata, T. Murata, W. Debinski, and R. K. Puri. 1997. The IL-13 receptor structure differs on various cell types and may share more than one compound with IL-4 receptor. J. Immunol. 158:756.
19. Ogata, H., D. Ford, D. Morgan, T. King, A. Minty, N. Vita, J. Stoeckler, C. Girasole, J. Morgan, and A. Maizel. 1998. Characterization of the IL-13 receptor on human B cells. J. Biol. Chem. 273:9864.
20. Roy, B., and M. K. Cathcart. 1998. Induction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytes. J. Biol. Chem. 273:32023.
21. Schnyder, B., S. Lugli, N. Feng, H. Etter, R. Lutz, B. Ryffel, K. Sugamura, H. Wurderli-Allenspach, and R. Moser. 1996. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common γ chain. Blood 87:4286.
22. Vita, N., S. Lefort, P. Laurent, D. Caput, and P. Ferrara. 1995. Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J. Biol. Chem. 270:3512.
23. Zurawski, S. M., F. J. Vega, B. Huyghe, and G. Zurawski. 1993. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12:2663.
24. Matthews, D. J., L. Hibbert, K. Friedrich, A. Minty, and R. E. Callard. 1997. X-SClD B cell responses to interleukin-4 and interleukin-13 mediated by a receptor complex that includes the interleukin-4 receptor α chain (p140) but not the γc chain. Eur. J. Immunol. 27:116.
25. Itoh, H., M. Mukoyama, R. E. Pratt, G. H. Gibbons, and V. J. Dzau. 1993. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to arigiotensin II. J. Clin. Invest. 91:2268.
26. Matthews, D. J., P. A. Clark, H. J. Morgan, R. J. Armitage, C. Kinnon, A. Minty, K. H. Grabstein, D. Caput, and P. Ferrara. 1995. Function of the interleukin-2 (IL-2) receptor γ-chain in biologic response of x-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15. Blood 85:38.
27. He, Y. W., and T. R. Malek. 1995. The IL-2 receptor γc chain does not function as a subunit shared by the IL-4 and IL-13 receptors. J. Immunol. 155:9.
28. Konig, B., A. Fischer, and W. Konig. 1995. Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D). Immunology 85:604.
29. Palmer-Crocker, R. L., C. Hughes, and J. Pober. 1996. IL-4 and IL-13 activate the Jak 2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the γc chain. J. Clin. Invest. 98:604.
30. Rolling, C., D. Treton, S. Pellegrini, P. Galanaud, and Y. Richard. 1996. IL-4 and IL-13 receptors share the γc chain and activate STAT6, STAT3, and STAT5 proteins in normal human B cells. FEBS Lett. 393:53.
31. Malabarba, M. G., H. Rui, H. H. J. Deutsch, J. Chung, F. S. Kalthoff, and W. L. Farrar. 1996. Interleukin-13 is a potent activator of Jak3 and STAT6 in cells expressing interleukin 2 receptor-γ and interleukin-4 receptor-α. Biochem. J. 319:865.
32. Obiri, N., T. Murata, W. Debinski, and R. Puri. 1997. Modulation of interleukin (IL)-13 binding and signaling by the γc chain of the IL-2 receptor. J. Biol. Chem. 272:20251.
33. Defrance, T., P. Carayon, G. Billian, J. C. Guillemot, A. Minty, D. Caput, and P. Ferrara. 1994. Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 179:135.
34. Colotta, F., F. Re, M. Muzio, N. Polentarutti, A. Minty, D. Caput, P. Farrara, and A. Mantovani. 1994. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J. Biol. Chem. 269:12403.
35. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. Galizzi, C. VanKooten, Y. Liu, F. Rousset, and S. Sailand. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881.
36. Billard, C., D. Caput, N. Vita, P. Ferrara, M. Orrico, P. Gaulard, L. Boumsell, A. Bensaussan, and J. Farcet. 1997. Interleukin-13 responsiveness and interleukin 13 receptor expression in non-Hodgkin's lymphoma and reactive lymph node B cells: modulation by CD40 activation. Eur. Cytokine Netw. 8:19.
37. Defrance, T., B. Vanbervliet, J. P. Aubry, and J. Banchereau. 1988. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2. J. Exp. Med. 168:1321.
38. Guo, J., F. Apiou, M. Mellerin, B. Lebeau, Y. Jacques, and S. Minvielle. 1997. Chromosome mapping and expression of the human interleukin-13 receptor. Genomics 42:141.
39. Morgan, J. W., D. M. Morgan, S. Lasky, D. Ford, N. Kouttab, and A. L. Maizel. 1996. Requirements for induction of vitamin D-mediated gene regulation in normal human B lymphocytes. J. Immunol. 157:2900.
40. Colligan, J. 1998. Current Protocols in Immunology. John Wiley & Sons, New York.
41. 3 modulates CD38 expression on human lymphocytes. J. Immunol. 157:4908.
42. Liu, Y.-J., C. Barthelemy, O. DeBouteiller, C. Arpin, I. Durand, and J. Banchereau. 1995. Memory B cells from human tonsils colonized mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity 2:239.
43. Arpin, C., J. Dechant, C. VanKooten, P. Merville, G. Grouard, F. Briere, J. Banchereau, and Y.-J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science 268:720.
44. Banchereau, J., and F. Fousset. 1992. Human B lymphocytes: phenotype, proliferation and differentiation. Adv. Immunol. 52:125.
45. Lugli, S., N. Feng, N. Heim, M. Adam, B. Schnyder, H. Etter, M. Yamage, H. Eugster, R. Lutz, G. Zuarwski, and R. Moser. 1997. Tumor necrosis factor α enhances the expression of the interleukin (IL)-4 receptor α chain on endothelial cells increasing IL-4 or IL-13-induced Stat6 activation. J. Biol. Chem. 272:5487.
46. Fluckinger, A. C., F. Briere, G. Zurawski, J. M. Bridon, and J. Banchereau. 1994. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukemia cells. Immunology 83:397.
47. Leonard, W. J. 1996. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Annu. Rev. Med. 47:229.
48. Manna, S. K., and B. B. Aggarwal. 1998. Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-κB, AP-1, and c-Jun N-terminal kinase: comparison with interleukin-13. J. Biol. Chem. 273:33333.
49. Lin, J. X., T. S. Migone, M. Tsang, M. Friedmann, J. A. Weatherbee, L. Xhou, A. Yamauchi, E. T. Bloom, J. Mietz, S. John, and W. J. Leonard. 1995. The role of shared receptor motifs and common STAT proteins in the generation of pleiotrophy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331.
50. Ahmed, R., and D. Gray. 1996. Immunological memory and protectivity immunity: understanding their relation. Science 272:54.
51. Chaouchi, N., C. Walton, C. Goujard, G. Tertian, A. Rudent, D. Caput, P. Ferrera, A. Minty, A. Vazquez, and J. F. Delfraissy. 1996. Inlerleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 87:1022.
52. Karray, S., T. DeFrance, H. Merle-Beral, J. Banchereau, P. Debre, and P. Galanaud. 1988. Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells. J. Exp. Med. 168:85.
53. Karray, S., A. Dautry-Varsat, M. Tsudo, H. Merle-Beral, P. Debre, and P. Galanaud. 1990. IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells. J. Immunol. 145:1152.
54. Lee, H. K., X. Xia, and Y. S. Choi. 1990. IL-4 blocks the up-regulation of IL-2 receptors induced by IL-2 in normal human B cells. J. Immunol. 144:3431.
55. Vazquez, A., S. Mills, and A. Maizel. 1989. Modulation of IL-2-induced human B cell proliferation in the presence of human 50 kDa B cell growth factor and IL-4. J. Immunol. 142:94.
56. Banchereau, J., P. dePaoli, A. Valli, E. Garcia, and F. Rousset 1991. Long term human B cell lines dependent on interleukin 4 and antibody to CD40. Science 151:70.